Breaking News Instant updates and real-time market news.

MDGEF

MediGene

$4.80 /

+ (+0.00%)

, GLSI

Greenwich LifeSciences

$35.13 /

-0.92 (-2.55%)

04:55
04/15/21
04/15
04:55
04/15/21
04:55

American Association for Cancer Research to hold a virtual meeting

AACR Virtual Annual Meeting 2021 will be held on April 9-15. Webcast Link

MDGEF

MediGene

$4.80 /

+ (+0.00%)

GLSI

Greenwich LifeSciences

$35.13 /

-0.92 (-2.55%)

JNCE

Jounce Therapeutics

$9.74 /

+0.485 (+5.24%)

ATNM

Actinium Pharmaceuticals

$7.80 /

+0.23 (+3.04%)

BDTX

Black Diamond Therapeutics

$24.70 /

-0.7199 (-2.83%)

CRSP

Crispr Therapeutics

$123.29 /

+2.34 (+1.93%)

HARP

Harpoon Therapeutics

$20.61 /

+0.73 (+3.67%)

ITOS

iTeos Therapeutics

$24.03 /

-1.24 (-4.91%)

REPL

Replimune Group

$30.50 /

+0.32 (+1.06%)

RVMD

Revolution Medicines

$39.79 /

+2.18 (+5.80%)

ZNTL

Zentalis

$47.04 /

+1.43 (+3.14%)

IMCR

Immunocore

$39.50 /

+6.8 (+20.80%)

PMVP

PMV Pharmaceuticals

$32.90 /

+0.06 (+0.18%)

ARVN

Arvinas

$62.89 /

+1.62 (+2.64%)

IOVA

Iovance Biotherapeutics

$30.00 /

-0.17 (-0.56%)

ADXS

Advaxis

/

+

AGEN

Agenus

$2.70 /

-0.015 (-0.55%)

BPTH

Bio-Path

$6.21 /

-0.41 (-6.19%)

INCY

Incyte

$82.13 /

+1.5 (+1.86%)

IMAB

I-Mab

$55.17 /

+5.42 (+10.89%)

MRSN

Mersana Therapeutics

$17.06 /

+0.89 (+5.50%)

RUBY

Rubius Therapeutics

$23.77 /

+1.27 (+5.64%)

PPBT

Purple Biotech

$4.04 /

+ (+0.00%)

SONN

Sonnet BioTherapeutics

$2.11 /

-0.02 (-0.94%)

STTK

Shattuck Labs

$32.98 /

+0.56 (+1.73%)

SURF

Surface Oncology

$7.35 /

+0.095 (+1.31%)

BGNE

BeiGene

$300.84 /

+0.84 (+0.28%)

CMPI

Checkmate Pharmaceuticals

$7.44 /

+0.3 (+4.20%)

BNGO

Bionano Genomics

$6.42 /

-0.47 (-6.82%)

  • 04

    May

  • 04

    May

  • 12

    May

  • 24

    May

  • 21

    Jun

  • 22

    Jun

  • 25

    Jul

  • 18

    Oct

  • 22

    Apr

  • 29

    May

  • 29

    May

  • 09

    Jun

  • 17

    Jun

  • 01

    Jul

  • 09

    Jul

  • 24

    Jul

  • 30

    Jul

  • 07

    Aug

  • 25

    Sep

  • 25

    Sep

  • 09

    Oct

  • 22

    Oct

  • 24

    Nov

  • 02

    Dec

  • 16

    Dec

  • 18

    Dec

  • 07

    Jan

  • 08

    Jan

  • 13

    Jan

  • 20

    Jan

  • 04

    Feb

  • 05

    Feb

  • 09

    Feb

  • 16

    Feb

  • 10

    Mar

  • 17

    Mar

MDGEF MediGene
$4.80 /

+ (+0.00%)

GLSI Greenwich LifeSciences
$35.13 /

-0.92 (-2.55%)

JNCE Jounce Therapeutics
$9.74 /

+0.485 (+5.24%)

04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
ATNM Actinium Pharmaceuticals
$7.80 /

+0.23 (+3.04%)

04/06/21 William Blair
Actinium's Q4 net loss roughly in line with projected loss, says William Blair
12/29/20 H.C. Wainwright
H.C. Wainwright keeps Buy on Actinium amid 'headline disappointment'
12/29/20 JonesTrading
Actinium selloff today 'clear buying opportunity,' says JonesTrading
11/05/20
Fly Intel: Top five analyst initiations
BDTX Black Diamond Therapeutics
$24.70 /

-0.7199 (-2.83%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
CRSP Crispr Therapeutics
$123.29 /

+2.34 (+1.93%)

03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/04/21 JMP Securities
Crispr Therapeutics initiated with an Outperform at JMP Securities
03/01/21 Barclays
Crispr Therapeutics price target raised to $140 from $113 at Barclays
02/17/21 Goldman Sachs
Crispr Therapeutics price target lowered to $189 from $193 at Goldman Sachs
HARP Harpoon Therapeutics
$20.61 /

+0.73 (+3.67%)

03/11/21 Roth Capital
Harpoon's 2020/2021 should be 'festival of data,' says Roth Capital
01/04/21 Roth Capital
Harpoon having fourth candidate in clinic 'impressive,' says Roth Capital
12/23/20 H.C. Wainwright
Harpoon Therapeutics assumed with a Buy at H.C. Wainwright
12/16/20 Wedbush
Replimune Group, Harpoon Therapeutics removed from Best Ideas List at Wedbush
ITOS iTeos Therapeutics
$24.03 /

-1.24 (-4.91%)

04/12/21 Piper Sandler
iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler
04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
04/05/21 Piper Sandler
Piper Sandler continues to recommend iTeos Therapeutics into data
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
REPL Replimune Group
$30.50 /

+0.32 (+1.06%)

02/05/21 H.C. Wainwright
Replimune Group price target raised to $60 from $58 at H.C. Wainwright
11/17/20 BTIG
Replimune Group initiated with a Buy at BTIG
11/10/20 H.C. Wainwright
Replimune Group price target raised to $58 from $54 at H.C. Wainwright
RVMD Revolution Medicines
$39.79 /

+2.18 (+5.80%)

03/03/21 SVB Leerink
Revolution Medicines price target raised to $55 from $46 at SVB Leerink
01/29/21 JPMorgan
Revolution Medicines price target raised to $44 from $33 at JPMorgan
10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
ZNTL Zentalis
$47.04 /

+1.43 (+3.14%)

04/12/21 SVB Leerink
Zentalis price target raised to $60 from $44 at SVB Leerink
03/26/21 H.C. Wainwright
Zentalis price target raised to $65 from $43 at H.C. Wainwright
01/19/21 Wedbush
Zentalis initiated with an Outperform at Wedbush
09/28/20 Cantor Fitzgerald
Cantor starts 'underappreciated' Zentalis with Overweight, $44 target
IMCR Immunocore
$39.50 /

+6.8 (+20.80%)

03/02/21 Jefferies
Immunocore initiated with a Buy at Jefferies
03/02/21 JPMorgan
Immunocore initiated with an Overweight at JPMorgan
03/02/21 Goldman Sachs
Immunocore initiated with a Neutral at Goldman Sachs
PMVP PMV Pharmaceuticals
$32.90 /

+0.06 (+0.18%)

10/20/20 Evercore ISI
PMV Pharmaceuticals initiated with an Outperform at Evercore ISI
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 Cowen
PMV Pharmaceuticals initiated with an Outperform at Cowen
ARVN Arvinas
$62.89 /

+1.62 (+2.64%)

03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
03/30/21 Cantor Fitzgerald
Arvinas price target raised to $140 from $121 at Cantor Fitzgerald
03/01/21 Roth Capital
Arvinas reaffirmed 'major catalysts' for 2021, says Roth Capital
01/19/21 Oppenheimer
Arvinas price target raised to $100 from $80 at Oppenheimer
IOVA Iovance Biotherapeutics
$30.00 /

-0.17 (-0.56%)

04/13/21 Cowen
Cowen starts Instil Bio at Outperform on 'second-mover advantage'
03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
ADXS Advaxis
/

+

AGEN Agenus
$2.70 /

-0.015 (-0.55%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
09/22/20 B. Riley
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
BPTH Bio-Path
$6.21 /

-0.41 (-6.19%)

04/06/21 H.C. Wainwright
Bio-Path price target raised to $12 from $10 at H.C. Wainwright
04/05/21 Roth Capital
Bio-Path triple regimen data 'highly favorable,' says Roth Capital
03/11/21 Roth Capital
Bio-Path Holdings initiated with a Buy at Roth Capital
11/16/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $10 from $12 at H.C. Wainwright
INCY Incyte
$82.13 /

+1.5 (+1.86%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
IMAB I-Mab
$55.17 /

+5.42 (+10.89%)

03/15/21 Needham
I-MAB initiated with a Buy at Needham
03/03/21 H.C. Wainwright
I-MAB price target raised to $75 from $55 at H.C. Wainwright
02/25/21
Fly Intel: Top five analyst initiations
02/25/21 Piper Sandler
I-MAB initiated with an Overweight at Piper Sandler
MRSN Mersana Therapeutics
$17.06 /

+0.89 (+5.50%)

03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
12/02/20 Stifel
Mersana Therapeutics initiated with a Buy at Stifel
09/29/20 JPMorgan
Mersana Therapeutics resumed with a Neutral at JPMorgan
RUBY Rubius Therapeutics
$23.77 /

+1.27 (+5.64%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PPBT Purple Biotech
$4.04 /

+ (+0.00%)

12/31/20 H.C. Wainwright
H.C. Wainwright reiterates Buy, $25 price target on Purple Biotech
SONN Sonnet BioTherapeutics
$2.11 /

-0.02 (-0.94%)

09/04/20 Chardan
Sonnet BioTherapeutics price target raised to $8 from $7 at Chardan
06/05/20 Chardan
Sonnet BioTherapeutics initiated with a Buy at Chardan
STTK Shattuck Labs
$32.98 /

+0.56 (+1.73%)

04/14/21 Berenberg
Shattuck Labs initiated with a Buy at Berenberg
01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
11/03/20 Needham
Shattuck Labs initiated with a Buy at Needham
SURF Surface Oncology
$7.35 /

+0.095 (+1.31%)

03/10/21 Wedbush
Surface Oncology risk/reward 'highly favorable' into data, says Wedbush
12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
09/04/20
Fly Intel: Top five analyst initiations
09/04/20 H.C. Wainwright
Surface Oncology initiated with a Buy at H.C. Wainwright
BGNE BeiGene
$300.84 /

+0.84 (+0.28%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
CMPI Checkmate Pharmaceuticals
$7.44 /

+0.3 (+4.20%)

03/19/21 Jefferies
Checkmate Pharmaceuticals price target lowered to $19 from $23 at Jefferies
09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
09/01/20 BofA
BofA starts Checkmate Pharmaceuticals at Neutral ahead of more 'de-risking'
09/01/20 BofA
Checkmate Pharmaceuticals initiated with a Neutral at BofA
BNGO Bionano Genomics
$6.42 /

-0.47 (-6.82%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Spirit Airlines views 2022 as 'recovery year' » 10:22
10/28/21
10/28
10:22
10/28/21
10:22
SAVE

Spirit Airlines

$21.86 /

-0.32 (-1.44%)

Says pandemic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAVE Spirit Airlines
$21.86 /

-0.32 (-1.44%)

SAVE Spirit Airlines
$21.86 /

-0.32 (-1.44%)

07:00 Today Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
SAVE Spirit Airlines
$21.86 /

-0.32 (-1.44%)

SAVE Spirit Airlines
$21.86 /

-0.32 (-1.44%)

SAVE Spirit Airlines
$21.86 /

-0.32 (-1.44%)

SAVE Spirit Airlines
$21.86 /

-0.32 (-1.44%)

Hot Stocks
Jacobs reports award of $8B U.S. Department of Energy contract » 10:21
10/28/21
10/28
10:21
10/28/21
10:21
J

Jacobs

$138.66 /

+2.58 (+1.90%)

, HON

Honeywell

$217.16 /

+1.43 (+0.66%)

Jacobs (J), as a member…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
J Jacobs
$138.66 /

+2.58 (+1.90%)

HON Honeywell
$217.16 /

+1.43 (+0.66%)

J Jacobs
$138.66 /

+2.58 (+1.90%)

06/25/21 Citi
Citi sees infrastructure framework as 'tailwind' for infrastructure companies
05/11/21 Benchmark
Jacobs Engineering price target raised to $160 from $130 at Benchmark
05/11/21 Citi
Jacobs Engineering price target raised to $164 from $156 at Citi
04/21/21 Citi
Jacobs Engineering price target raised to $156 from $129 at Citi
HON Honeywell
$217.16 /

+1.43 (+0.66%)

10/07/21 Wells Fargo
Honeywell initiated with an Equal Weight at Wells Fargo
09/10/21 Gordon Haskett
Gordon Haskett says three Honeywell jets spotted near Hexcel HQ
07/26/21 Deutsche Bank
Honeywell price target raised to $251 from $245 at Deutsche Bank
07/26/21 Barclays
Honeywell price target raised to $253 from $245 at Barclays
J Jacobs
$138.66 /

+2.58 (+1.90%)

HON Honeywell
$217.16 /

+1.43 (+0.66%)

J Jacobs
$138.66 /

+2.58 (+1.90%)

HON Honeywell
$217.16 /

+1.43 (+0.66%)

J Jacobs
$138.66 /

+2.58 (+1.90%)

HON Honeywell
$217.16 /

+1.43 (+0.66%)

HON Honeywell
$217.16 /

+1.43 (+0.66%)

Periodicals
Aurinia Pharmaceuticals up 4% after Betaville issues 'Rare Alert' » 10:19
10/28/21
10/28
10:19
10/28/21
10:19
AUPH

Aurinia Pharmaceuticals

$29.92 /

-0.01 (-0.03%)

, GSK

GlaxoSmithKline

$41.62 /

+1.16 (+2.87%)

, RHHBY

Roche

$48.04 /

-0.49 (-1.01%)

, OTSKY

Otsuka

$20.16 /

-0.18 (-0.88%)

, BMY

Bristol-Myers

$57.40 /

+0.88 (+1.56%)

Shares of Aurinia…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUPH Aurinia Pharmaceuticals
$29.92 /

-0.01 (-0.03%)

GSK GlaxoSmithKline
$41.62 /

+1.16 (+2.87%)

RHHBY Roche
$48.04 /

-0.49 (-1.01%)

OTSKY Otsuka
$20.16 /

-0.18 (-0.88%)

BMY Bristol-Myers
$57.40 /

+0.88 (+1.56%)

AUPH Aurinia Pharmaceuticals
$29.92 /

-0.01 (-0.03%)

05:50 Today Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform on valuation at Oppenheimer
05:14 Today Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
GSK GlaxoSmithKline
$41.62 /

+1.16 (+2.87%)

10/27/21 Wedbush
Wedbush recommends buying SpringsWorks shares ahead of BLENREP combo data
10/18/21 Berenberg
GlaxoSmithKline price target lowered to 1,540 GBp from 1,625 GBp at Berenberg
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
RHHBY Roche
$48.04 /

-0.49 (-1.01%)

10/21/21 Benchmark
Biogen, Roche calls 'not helpful for Ionis story,' says Benchmark
10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
10/13/21 Morgan Stanley
Roche price target raised to CHF 380 from CHF 370 at Morgan Stanley
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
OTSKY Otsuka
$20.16 /

-0.18 (-0.88%)

07/14/21 Goldman Sachs
Otsuka downgraded to Sell from Neutral at Goldman Sachs
06/17/21 Daiwa
Otsuka upgraded to Outperform from Neutral at Daiwa
03/15/21 Daiwa
Otsuka downgraded to Neutral from Outperform at Daiwa
BMY Bristol-Myers
$57.40 /

+0.88 (+1.56%)

10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
AUPH Aurinia Pharmaceuticals
$29.92 /

-0.01 (-0.03%)

GSK GlaxoSmithKline
$41.62 /

+1.16 (+2.87%)

RHHBY Roche
$48.04 /

-0.49 (-1.01%)

BMY Bristol-Myers
$57.40 /

+0.88 (+1.56%)

AUPH Aurinia Pharmaceuticals
$29.92 /

-0.01 (-0.03%)

GSK GlaxoSmithKline
$41.62 /

+1.16 (+2.87%)

RHHBY Roche
$48.04 /

-0.49 (-1.01%)

BMY Bristol-Myers
$57.40 /

+0.88 (+1.56%)

AUPH Aurinia Pharmaceuticals
$29.92 /

-0.01 (-0.03%)

GSK GlaxoSmithKline
$41.62 /

+1.16 (+2.87%)

RHHBY Roche
$48.04 /

-0.49 (-1.01%)

BMY Bristol-Myers
$57.40 /

+0.88 (+1.56%)

AUPH Aurinia Pharmaceuticals
$29.92 /

-0.01 (-0.03%)

GSK GlaxoSmithKline
$41.62 /

+1.16 (+2.87%)

BMY Bristol-Myers
$57.40 /

+0.88 (+1.56%)

Hot Stocks
Spirit delaying return to full fleet utilization to late 2022/early 2023  10:18
10/28/21
10/28
10:18
10/28/21
10:18
SAVE

Spirit Airlines

$21.97 /

-0.21 (-0.95%)

 
ShowHide Related Items >><<
SAVE Spirit Airlines
$21.97 /

-0.21 (-0.95%)

SAVE Spirit Airlines
$21.97 /

-0.21 (-0.95%)

07:00 Today Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
SAVE Spirit Airlines
$21.97 /

-0.21 (-0.95%)

SAVE Spirit Airlines
$21.97 /

-0.21 (-0.95%)

SAVE Spirit Airlines
$21.97 /

-0.21 (-0.95%)

SAVE Spirit Airlines
$21.97 /

-0.21 (-0.95%)

Hot Stocks
Spirit Airlines considering new crew bases following August issues  10:17
10/28/21
10/28
10:17
10/28/21
10:17
SAVE

Spirit Airlines

$21.99 /

-0.19 (-0.86%)

 
ShowHide Related Items >><<
SAVE Spirit Airlines
$21.99 /

-0.19 (-0.86%)

SAVE Spirit Airlines
$21.99 /

-0.19 (-0.86%)

07:00 Today Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
SAVE Spirit Airlines
$21.99 /

-0.19 (-0.86%)

SAVE Spirit Airlines
$21.99 /

-0.19 (-0.86%)

SAVE Spirit Airlines
$21.99 /

-0.19 (-0.86%)

SAVE Spirit Airlines
$21.99 /

-0.19 (-0.86%)

Technical Analysis
NASDAQ market internals summary » 10:17
10/28/21
10/28
10:17
10/28/21
10:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 10:16
10/28/21
10/28
10:16
10/28/21
10:16
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Options
AGNC Investment Corp. put volume heavy and directionally bearish » 10:15
10/28/21
10/28
10:15
10/28/21
10:15
AGNC

AGNC Investment

$15.87 /

-0.38 (-2.34%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGNC AGNC Investment
$15.87 /

-0.38 (-2.34%)

AGNC AGNC Investment
$15.87 /

-0.38 (-2.34%)

05:10 Today JMP Securities
AGNC Investment downgraded to Market Perform from Outperform at JMP Securities
10/27/21 Barclays
AGNC Investment downgraded to Equal Weight from Overweight at Barclays
10/06/21 Piper Sandler
AGNC Investment downgraded to Neutral from Overweight at Piper Sandler
07/28/21 Barclays
AGNC Investment price target lowered to $17 from $18 at Barclays
AGNC AGNC Investment
$15.87 /

-0.38 (-2.34%)

AGNC AGNC Investment
$15.87 /

-0.38 (-2.34%)

AGNC AGNC Investment
$15.87 /

-0.38 (-2.34%)

General news
U.S. pending home sales index dropped -2.3% to 116.7 in September » 10:15
10/28/21
10/28
10:15
10/28/21
10:15
$ECON

Economic Data

/

+

U.S. pending home sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Spirit Airlines sees FY21 CapEx about $290M » 10:12
10/28/21
10/28
10:12
10/28/21
10:12
SAVE

Spirit Airlines

$22.06 /

-0.12 (-0.54%)

Sees Q4 EBITDA margin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAVE Spirit Airlines
$22.06 /

-0.12 (-0.54%)

SAVE Spirit Airlines
$22.06 /

-0.12 (-0.54%)

07:00 Today Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
SAVE Spirit Airlines
$22.06 /

-0.12 (-0.54%)

SAVE Spirit Airlines
$22.06 /

-0.12 (-0.54%)

SAVE Spirit Airlines
$22.06 /

-0.12 (-0.54%)

SAVE Spirit Airlines
$22.06 /

-0.12 (-0.54%)

Hot Stocks
Spirit Airlines says Q4 revenue tracking in line with 4Q19  10:11
10/28/21
10/28
10:11
10/28/21
10:11
SAVE

Spirit Airlines

$22.18 /

+ (+0.00%)

 
ShowHide Related Items >><<
SAVE Spirit Airlines
$22.18 /

+ (+0.00%)

SAVE Spirit Airlines
$22.18 /

+ (+0.00%)

07:00 Today Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
SAVE Spirit Airlines
$22.18 /

+ (+0.00%)

SAVE Spirit Airlines
$22.18 /

+ (+0.00%)

SAVE Spirit Airlines
$22.18 /

+ (+0.00%)

SAVE Spirit Airlines
$22.18 /

+ (+0.00%)

Hot Stocks
Spirit Airlines: Yields, loads for holiday season looking 'quite healthy'  10:09
10/28/21
10/28
10:09
10/28/21
10:09
SAVE

Spirit Airlines

$22.07 /

-0.11 (-0.50%)

 
ShowHide Related Items >><<
SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

07:00 Today Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

Earnings
Spirit Airlines sees Q4 revenue $938M-$975M, consensus $1.03B  10:08
10/28/21
10/28
10:08
10/28/21
10:08
SAVE

Spirit Airlines

$22.07 /

-0.11 (-0.50%)

 
ShowHide Related Items >><<
SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

07:00 Today Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

SAVE Spirit Airlines
$22.07 /

-0.11 (-0.50%)

Hot Stocks
Spirit Airlines sees Q4 capacity up 11.2% vs. 4Q19  10:08
10/28/21
10/28
10:08
10/28/21
10:08
SAVE

Spirit Airlines

$22.03 /

-0.15 (-0.68%)

 
ShowHide Related Items >><<
SAVE Spirit Airlines
$22.03 /

-0.15 (-0.68%)

SAVE Spirit Airlines
$22.03 /

-0.15 (-0.68%)

07:00 Today Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
SAVE Spirit Airlines
$22.03 /

-0.15 (-0.68%)

SAVE Spirit Airlines
$22.03 /

-0.15 (-0.68%)

SAVE Spirit Airlines
$22.03 /

-0.15 (-0.68%)

SAVE Spirit Airlines
$22.03 /

-0.15 (-0.68%)

On The Fly
Alibaba downgrade, Nio initiation among today's top calls on Wall Street » 10:06
10/28/21
10/28
10:06
10/28/21
10:06
BJ

BJ's Wholesale

$58.76 /

-0.355 (-0.60%)

, BABA

Alibaba

$167.49 /

-1.74 (-1.03%)

, JD

JD.com

$79.25 /

-1.57 (-1.94%)

, NIO

Nio

$39.47 /

+0.165 (+0.42%)

, LI

Li Auto

$33.25 /

+0.58 (+1.78%)

, XPEV

XPeng

$46.40 /

+0.41 (+0.89%)

, SHW

Sherwin-Williams

$318.29 /

+0.9 (+0.28%)

, TEVA

Teva

$8.72 /

-0.215 (-2.41%)

Check out today's top…

ShowHide Related Items >><<
BJ BJ's Wholesale
$58.76 /

-0.355 (-0.60%)

BABA Alibaba
$167.49 /

-1.74 (-1.03%)

JD JD.com
$79.25 /

-1.57 (-1.94%)

NIO Nio
$39.47 /

+0.165 (+0.42%)

LI Li Auto
$33.25 /

+0.58 (+1.78%)

XPEV XPeng
$46.40 /

+0.41 (+0.89%)

SHW Sherwin-Williams
$318.29 /

+0.9 (+0.28%)

TEVA Teva
$8.72 /

-0.215 (-2.41%)

BJ BJ's Wholesale
$58.76 /

-0.355 (-0.60%)

06:42 Today BofA
BJ's Wholesale downgraded to Neutral from Buy at BofA
06:05 Today BofA
BJ's Wholesale downgraded to Neutral from Buy at BofA
09/29/21 Loop Capital
BJ's Wholesale price target raised to $65 from $60 at Loop Capital
08/23/21 Credit Suisse
BJ's Wholesale price target raised to $60 from $52 at Credit Suisse
BABA Alibaba
$167.49 /

-1.74 (-1.03%)

08:55 Today Vertical Group
Alibaba downgraded to Mixed from Bullish at Vertical Group
10/25/21 Truist
Alibaba price target lowered to $230 from $260 at Truist
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 KeyBanc
Alibaba price target lowered to $200 from $250 at KeyBanc
JD JD.com
$79.25 /

-1.57 (-1.94%)

08:56 Today Vertical Group
JD.com downgraded to Mixed from Bullish at Vertical Group
10/25/21 Mizuho
JD.com price target raised to $95 from $85 at Mizuho
09/15/21 Stifel
JD.com price target raised to $100 from $90 at Stifel
09/03/21 Stifel
JD.com price target raised to $90 from $85 at Stifel
NIO Nio
$39.47 /

+0.165 (+0.42%)

09:55 Today
Fly Intel: Top five analyst initiations
06:33 Today Bernstein
Bernstein starts Nio at Market Perform, cites competition concerns
06:21 Today Bernstein
Nio initiated with a Market Perform at Bernstein
10/14/21 Nomura
Li Auto initiated with a Buy at Nomura
LI Li Auto
$33.25 /

+0.58 (+1.78%)

09:55 Today
Fly Intel: Top five analyst initiations
06:33 Today Bernstein
Bernstein starts Li Auto at Outperform, sees EVs as 'future' of Chinese autos
06:21 Today Bernstein
Li Auto initiated with an Outperform at Bernstein
10/14/21 Nomura
Li Auto initiated with a Buy at Nomura
XPEV XPeng
$46.40 /

+0.41 (+0.89%)

09:55 Today
Fly Intel: Top five analyst initiations
06:33 Today Bernstein
Bernstein starts XPeng at Outperform, sees EVs as 'future' of Chinese autos
06:21 Today Bernstein
XPeng initiated with an Outperform at Bernstein
10/14/21 Nomura
Li Auto initiated with a Buy at Nomura
SHW Sherwin-Williams
$318.29 /

+0.9 (+0.28%)

09:55 Today
Fly Intel: Top five analyst downgrades
08:29 Today BMO Capital
Sherwin-Williams price target raised to $355 from $300 at BMO Capital
07:28 Today RBC Capital
Sherwin-Williams price target raised to $360 from $330 at RBC Capital
07:23 Today BofA
Sherwin-Williams downgraded to Neutral at BofA on 'dual headwinds'
TEVA Teva
$8.72 /

-0.215 (-2.41%)

06:17 Today Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
04:47 Today Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
BJ BJ's Wholesale
$58.76 /

-0.355 (-0.60%)

BABA Alibaba
$167.49 /

-1.74 (-1.03%)

JD JD.com
$79.25 /

-1.57 (-1.94%)

NIO Nio
$39.47 /

+0.165 (+0.42%)

LI Li Auto
$33.25 /

+0.58 (+1.78%)

XPEV XPeng
$46.40 /

+0.41 (+0.89%)

SHW Sherwin-Williams
$318.29 /

+0.9 (+0.28%)

TEVA Teva
$8.72 /

-0.215 (-2.41%)

  • 13
    Aug
  • 14
    Dec
  • 09
    Dec
  • 04
    Dec
BJ BJ's Wholesale
$58.76 /

-0.355 (-0.60%)

BABA Alibaba
$167.49 /

-1.74 (-1.03%)

JD JD.com
$79.25 /

-1.57 (-1.94%)

NIO Nio
$39.47 /

+0.165 (+0.42%)

LI Li Auto
$33.25 /

+0.58 (+1.78%)

XPEV XPeng
$46.40 /

+0.41 (+0.89%)

SHW Sherwin-Williams
$318.29 /

+0.9 (+0.28%)

TEVA Teva
$8.72 /

-0.215 (-2.41%)

BJ BJ's Wholesale
$58.76 /

-0.355 (-0.60%)

BABA Alibaba
$167.49 /

-1.74 (-1.03%)

JD JD.com
$79.25 /

-1.57 (-1.94%)

NIO Nio
$39.47 /

+0.165 (+0.42%)

LI Li Auto
$33.25 /

+0.58 (+1.78%)

XPEV XPeng
$46.40 /

+0.41 (+0.89%)

SHW Sherwin-Williams
$318.29 /

+0.9 (+0.28%)

TEVA Teva
$8.72 /

-0.215 (-2.41%)

BABA Alibaba
$167.49 /

-1.74 (-1.03%)

JD JD.com
$79.25 /

-1.57 (-1.94%)

NIO Nio
$39.47 /

+0.165 (+0.42%)

LI Li Auto
$33.25 /

+0.58 (+1.78%)

XPEV XPeng
$46.40 /

+0.41 (+0.89%)

TEVA Teva
$8.72 /

-0.215 (-2.41%)

General news
Treasury Action: the bond market continues to twist and turn » 10:05
10/28/21
10/28
10:05
10/28/21
10:05
$ECON

Economic Data

/

+

Treasury Action: the bond…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish » 10:05
10/28/21
10/28
10:05
10/28/21
10:05
AUPH

Aurinia Pharmaceuticals

$29.94 /

+0.01 (+0.03%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUPH Aurinia Pharmaceuticals
$29.94 /

+0.01 (+0.03%)

AUPH Aurinia Pharmaceuticals
$29.94 /

+0.01 (+0.03%)

05:50 Today Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform on valuation at Oppenheimer
05:14 Today Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
AUPH Aurinia Pharmaceuticals
$29.94 /

+0.01 (+0.03%)

AUPH Aurinia Pharmaceuticals
$29.94 /

+0.01 (+0.03%)

AUPH Aurinia Pharmaceuticals
$29.94 /

+0.01 (+0.03%)

AUPH Aurinia Pharmaceuticals
$29.94 /

+0.01 (+0.03%)

General news
Wall Street opened higher » 10:05
10/28/21
10/28
10:05
10/28/21
10:05
$ECON

Economic Data

/

+

Wall Street opened…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Spirit Airlines: July was 'solidly profitable' » 10:04
10/28/21
10/28
10:04
10/28/21
10:04
SAVE

Spirit Airlines

$21.91 /

-0.27 (-1.22%)

Comments taken from Q3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAVE Spirit Airlines
$21.91 /

-0.27 (-1.22%)

SAVE Spirit Airlines
$21.91 /

-0.27 (-1.22%)

07:00 Today Deutsche Bank
Spirit Airlines price target lowered to $30 from $36 at Deutsche Bank
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/01/21
Fly Intel: Top five analyst downgrades
10/01/21 JPMorgan
Spirit Airlines downgraded to Neutral with $34 target at JPMorgan
SAVE Spirit Airlines
$21.91 /

-0.27 (-1.22%)

SAVE Spirit Airlines
$21.91 /

-0.27 (-1.22%)

SAVE Spirit Airlines
$21.91 /

-0.27 (-1.22%)

SAVE Spirit Airlines
$21.91 /

-0.27 (-1.22%)

General news
September pending home sales index 116.7  10:03
10/28/21
10/28
10:03
10/28/21
10:03
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
September pending home sales index down 2.3% vs. last month, consensus 1.7%  10:03
10/28/21
10/28
10:03
10/28/21
10:03
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
MaxCyte signs strategic platform license with Nkarta » 10:03
10/28/21
10/28
10:03
10/28/21
10:03
MXCT

MaxCyte

$10.52 /

-0.02 (-0.19%)

, NKTX

Nkarta

$16.45 /

-0.04 (-0.24%)

MaxCyte (MXCT) announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MXCT MaxCyte
$10.52 /

-0.02 (-0.19%)

NKTX Nkarta
$16.45 /

-0.04 (-0.24%)

MXCT MaxCyte
$10.52 /

-0.02 (-0.19%)

08/24/21
Fly Intel: Top five analyst initiations
08/24/21 Stephens
MaxCyte initiated with an Overweight at Stephens
08/24/21 William Blair
Blair starts MaxCyte at Outperform, sees 'one-of-a-kind opportunity'
08/24/21 William Blair
MaxCyte initiated with an Outperform at William Blair
NKTX Nkarta
$16.45 /

-0.04 (-0.24%)

07/15/21 Oppenheimer
Nkarta initiated with an Outperform at Oppenheimer
06/29/21 Cantor Fitzgerald
Nkarta price target lowered to $71 from $78 at Cantor Fitzgerald
03/18/21 Cantor Fitzgerald
Nkarta initiated with an Overweight at Cantor Fitzgerald
03/17/21 Cantor Fitzgerald
Nkarta initiated with an Overweight at Cantor Fitzgerald
NKTX Nkarta
$16.45 /

-0.04 (-0.24%)

  • 30
    Jul
MXCT MaxCyte
$10.52 /

-0.02 (-0.19%)

Hot Stocks
Dollar Tree, Instacart expand partnership for same-day delivery » 10:02
10/28/21
10/28
10:02
10/28/21
10:02
DLTR

Dollar Tree

$105.98 /

+1.45 (+1.39%)

Instacart and Dollar Tree…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLTR Dollar Tree
$105.98 /

+1.45 (+1.39%)

DLTR Dollar Tree
$105.98 /

+1.45 (+1.39%)

10/01/21 KeyBanc
Dollar Tree downgraded to Sector Weight from Overweight at KeyBanc
09/30/21 KeyBanc
Dollar Tree downgraded to Sector Weight from Overweight at KeyBanc
09/29/21 Jefferies
Added price points could have multiple benefits for Dollar Tree, says Jefferies
08/27/21 Telsey Advisory
Telsey downgrades Dollar Tree on inability to pass on higher costs
DLTR Dollar Tree
$105.98 /

+1.45 (+1.39%)

DLTR Dollar Tree
$105.98 /

+1.45 (+1.39%)

DLTR Dollar Tree
$105.98 /

+1.45 (+1.39%)

DLTR Dollar Tree
$105.98 /

+1.45 (+1.39%)

Hot Stocks
BAE Systems reports $26M contract to equip U.S. Navy Constellation frigates » 10:01
10/28/21
10/28
10:01
10/28/21
10:01
BAESY

BAE Systems

$31.18 /

-0.22 (-0.70%)

BAE Systems announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAESY BAE Systems
$31.18 /

-0.22 (-0.70%)

BAESY BAE Systems
$31.18 /

-0.22 (-0.70%)

10/14/21 Kepler Cheuvreux
BAE Systems initiated with a Buy at Kepler Cheuvreux
10/14/21 Kepler Cheuvreux
BAE Systems initiated with a Buy at Kepler Cheuvreux
08/04/21 JPMorgan
BAE Systems downgraded to Neutral from Overweight at JPMorgan
08/02/21 UBS
BAE Systems price target raised to 575 GBp from 565 GBp at UBS
BAESY BAE Systems
$31.18 /

-0.22 (-0.70%)

Hot Stocks
IronNet falls -17.0% » 10:00
10/28/21
10/28
10:00
10/28/21
10:00
IRNT

IronNet

$13.67 /

-2.56 (-15.77%)

IronNet is down -17.0%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRNT IronNet
$13.67 /

-2.56 (-15.77%)

IRNT IronNet
$13.67 /

-2.56 (-15.77%)

09/29/21
Fly Intel: Top five analyst initiations
09/29/21 Jefferies
IronNet initiated with a Hold at Jefferies
09/27/21 Needham
IronNet initiated with a Buy at Needham
09/27/21 Needham
IronNet initiated with a Buy at Needham
IRNT IronNet
$13.67 /

-2.56 (-15.77%)

IRNT IronNet
$13.67 /

-2.56 (-15.77%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.